+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Omnicell Inc (OMCL) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 59 Pages
  • May 2025
  • GlobalData
  • ID: 4225248
Omnicell Inc (OMCL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the analyst to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Omnicell Inc (Omnicell) develops and implements advanced medication management solutions. The company offers products and services, including medication and supply dispensing systems, robotics, software workflows, and operational analytics. Its EnlivenHealth brand, offers solutions for patient engagement and clinical workflows. Omnicell's products and services are utilized by healthcare providers across inpatient, outpatient, and retail settings. The company distributes its products and services directly to customers in the US and Canada; through direct sales teams in the UK, France, Germany, and Australia; and relying on distributors for the Middle East, Asia, and Latin America. Omnicell operates in the US, the UK, and Germany. Omnicell is headquartered in Fort Worth, Texas, the US.

Omnicell Inc Key Recent Developments

  • May 22, 2025: Omnicell Expects Improved Profitability, Updates Second Quarter and Full Year 2025 Profit Outlook and Announces a New Stock Repurchase Program
  • May 14, 2025: Omnicell Opens New Innovation Lab in Austin, Texas
  • Mar 24, 2025: Omnicell Welcomes Perry A. Genova, PhD, as Chief Technology Officer
  • Mar 12, 2025: Omnicell Announces Chief Financial Officer Transition

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Omnicell Inc - Key Facts
  • Omnicell Inc - Key Employees
  • Omnicell Inc - Key Employee Biographies
  • Omnicell Inc - Major Products and Services
  • Omnicell Inc - History
  • Omnicell Inc - Company Statement
  • Omnicell Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Omnicell Inc - Business Description
  • Other Break-up: Connected devices, software licenses, and other
  • Performance
  • Other Break-up: Consumables
  • Performance
  • Other Break-up: SaaS and Expert Service
  • Performance
  • Other Break-up: Technical services
  • Performance
  • Geographical Segment: Rest of World
  • Performance
  • Geographical Segment: United States
  • Performance
  • R&D Overview
  • Omnicell Inc - Corporate Strategy
  • Omnicell Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Omnicell Inc - Strengths
  • Omnicell Inc - Weaknesses
  • Omnicell Inc - Opportunities
  • Omnicell Inc - Threats
  • Omnicell Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
  • Omnicell Inc, Recent Deals Summary
Section 4 - Company’s Recent Developments
  • May 22, 2025: Omnicell Expects Improved Profitability, Updates Second Quarter and Full Year 2025 Profit Outlook and Announces a New Stock Repurchase Program
  • May 14, 2025: Omnicell Opens New Innovation Lab in Austin, Texas
  • Mar 24, 2025: Omnicell Welcomes Perry A. Genova, PhD, as Chief Technology Officer
  • Mar 12, 2025: Omnicell Announces Chief Financial Officer Transition
  • Dec 09, 2024: Omnicell Unveils Omnisphere
  • Sep 25, 2024: Omnicell Hires Nnamdi Njoku as Executive Vice President and Chief Operating Officer
  • Aug 01, 2024: Omnicell Reports Q2 2024 Results
  • Aug 01, 2024: EnlivenHealth and Good Neighbor Pharmacy Seek to Empower Independent Pharmacies with New Clinical Scope of Practice and Reimbursement Solution
  • May 02, 2024: Omnicell Releases Q1 2024 Results
  • Feb 08, 2024: Omnicell Reports Results for Fiscal Year and Q4 Ended December 31, 2023
Section 5 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Analyst
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Omnicell Inc, Key Facts
  • Omnicell Inc, Key Employees
  • Omnicell Inc, Key Employee Biographies
  • Omnicell Inc, Major Products and Services
  • Omnicell Inc, History
  • Omnicell Inc, Other Locations
  • Omnicell Inc, Subsidiaries
  • Omnicell Inc, Key Competitors
  • Omnicell Inc, Ratios based on current share price
  • Omnicell Inc, Annual Ratios
  • Omnicell Inc, Interim Ratios
  • Omnicell Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Omnicell Inc, Performance Chart (2020 - 2024)
  • Omnicell Inc, Ratio Charts

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Yuyama Co Ltd
  • TECSYS Inc
  • Swisslog Healthcare AG
  • Par Excellence Systems, Inc.
  • Medicine-On-Time, LLC
  • McKesson Corp
  • DIH Technologies Co.
  • Digital Pharmacist Inc
  • Cerner Corp